Industries > Pharma > Biologics Market Trends and Forecasts 2018-2028

Biologics Market Trends and Forecasts 2018-2028

Protein Therapeutics, Monoclonal Antibodies, Fusion Proteins, Regenerative Medicines, Insulin, Other Recombinant Hormones, Plasma & Recombinant Coagulating Factors, Interferons, Enzyme Replacement, Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

PUBLISHED: 14 November 2018
PAGES: 303
PRODUCT CODE: PHA0341

Clear
WOOCS 2.2.1

The global biologics market is estimated to reach $250bn in 2023. The market is expected to grow at a CAGR of 4.8% from 2018 to 2023. In 2017, the monoclonal antibodies submarket held 36.3% share of the global biologics market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 303-page report you will receive 166 charts– all unavailable elsewhere.

The 303-page report provides clear detailed insight into the global biologics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Biologics Market outlook from 2018-2028

Global Biologics Submarkets analysis and forecast from 2018-2028:
Protein therapeutics, with sub-forecasting for insulin, other recombinant hormones, plasma and recombinant coagulating factors, interferons, enzyme replacement and other agents
Monoclonal antibodies (mAbs)
Fusion proteins
Regenerative medicine, with sub-forecasting for stem cell treatment, tissue engineering and gene therapy
Vaccines

• Analysis and forecast from 2018-2028 for selected leading biologics in the market:
• Lantus
• NovoLog/NovoRapid
• Humalog
• Avonex
• Rebif
• Humira
• Remicade
• Tysabri
• Herceptin
• Kadcyla
• Perjeta
• Enbrel
• Eylea
• OsteoCel Plus
• Trinity Evolution and Trinity Elite
• Apligraf
• Dermagraft
• IMLYGIC

Biologics Market Trends and Forecasts 2018-2028

• This report provides individual revenue forecasts from 2018-2028 for these national markets:
• The US
• Japan
• Germany
• France
• UK
• Italy
• Spain
• China
• India
• Russia
• Brazil

• Our study discusses the selected leading companies that are the major players in the biologics market:
• AbbVie
• Amgen
• AstraZeneca
• Bayer
• Eli Lilly
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis
• Pfizer
• Roche
• Sanofi S.A.

• This report discusses factors that drive and restrain this market. As well as opportunities and trends in this market.

• This report discusses the SWOT and STEP Analysis of the biologics market.

Visiongain’s study is intended for anyone requiring commercial analyses for the biologics market. You find data, trends and predictions.

Buy our report today Biologics Market Forecasts : Protein Therapeutics, Monoclonal Antibodies, Fusion Proteins, Regenerative Medicines, Insulin, Other Recombinant Hormones, Plasma & Recombinant Coagulating Factors, Interferons, Enzyme Replacement, Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Biologics Market Trends and Forecasts 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Biologics Market Trends and Forecasts 2018-2028


Latest Pharma news

Visiongain Publishes 3D Printing for Healthcare Market Report 2021-2031

The growing use of this technology in many applications such as transplantation, drug delivery, 3D printed organs, and many others in the healthcare industry is one of the key drivers in the global 3D Printing in Healthcare Market.

02 August 2021

READ

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Categories